For the quarter ended September 2024, Elevance Health (ELV) reported revenue of $44.72 billion, up 5.3% over the same period last year. EPS came in at $8.37, compared to $8.99 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $43.26 billion, representing a surprise of +3.37%. The company delivered an EPS surprise of -13.71%, with the consensus EPS estimate being $9.70. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...